Compass Therapeutics Inc. (CMPX)
NASDAQ: CMPX
· Real-Time Price · USD
2.60
-0.09 (-3.35%)
At close: Jun 26, 2025, 3:59 PM
2.73
5.20%
After-hours: Jun 26, 2025, 07:46 PM EDT
-3.35% (1D)
| Bid | 2.19 |
| Market Cap | 358.84M |
| Revenue (ttm) | 850K |
| Net Income (ttm) | -55.22M |
| EPS (ttm) | -0.4 |
| PE Ratio (ttm) | -6.49 |
| Forward PE | -4.71 |
| Analyst | Buy |
| Ask | 2.8 |
| Volume | 670,937 |
| Avg. Volume (20D) | 1,437,456 |
| Open | 2.68 |
| Previous Close | 2.69 |
| Day's Range | 2.58 - 2.68 |
| 52-Week Range | 0.77 - 4.08 |
| Beta | 1.22 |
About CMPX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CMPX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CMPX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+17.89%
Compass Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
4 months ago
+6.51%
Compass Therapeutics shares are trading higher after Guggenhiem initiated coverage on the stock with a Buy rating and announced a price target of $12.
2 weeks ago · https://www.defenseworld.net
Squarepoint Ops LLC Acquires New Holdings in Compass Therapeutics, Inc. (NASDAQ:CMPX)Squarepoint Ops LLC acquired a new stake in Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and...
